Objectives to provide accurate information about the global prevalence of human
papillomavirus (HPV) in oropharyngeal squamous cell carcinomas (OPSCC). Material and …

Despite the increasingly precise genomic characterization of HNSCCs, precision medicine
is struggling to find its place in the management of HNSCCs. Inclusion of enriched …

Background Mutations of the tumour-suppressor gene TP53 are the most frequent somatic
genomic alterations in head and neck squamous cell carcinoma (HNSCC). However, it is not …

Introduction HPV-driven oropharyngeal cancer (OPC) patients have a better prognosis than
their HPV-negative counterparts but several studies have suggested that among HPV …

Background When treated nonsurgically with definitive chemoradiation, smokers with
human papillomavirus (HPV)–positive oropharyngeal squamous cell carcinoma (OPSCC) …

Purpose To characterize the significance of patient-level influences, including smoking
history, on oncologic outcomes in human papillomavirus (HPV)-mediated oropharyngeal …

Background The goal of this review was to present an overview of the currently identified
molecular parameters in head and neck squamous cell carcinoma (HNSCC) of nonsmokers …

Background This study reports long‐term head and neck cancer (HNC) patient‐reported
symptoms using the MD Anderson Symptom Inventory Head and Neck Cancer Module …

Background/Aim: Human papillomavirus-positive (HPV+) tonsillar and base of tongue
squamous cell carcinoma (TSCC/BOTSCC) have better outcome than corresponding HPV …

A systematic review (SR) and meta-analysis were conducted to determine the prevalence of
PI3K-AKT-mTOR signaling pathway mutations in patients with head and neck cancer (HNC) …